Methylprednisolone Sodium Succinate from Canada
Methylprednisolone sodium succinate, a derivative salt ester of the prednisone family, serves as a potent synthetic glucocorticoid for acute inflammation management via IV administration. It qualifies for HTS 2937.29.90.30 as a structural analogue salt of prednisone used primarily as a hormone. The formulation allows for high-dose pulse therapy.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide pharmacopeial compliance (Ph
• Eur./USP); ensure cold chain validation for hygroscopic salts
• Pitfall: declaring as 'intermediate' shifts to different chapter
• Track batch genealogy for recall compliance